Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Total 13F shares
-
38,246,560
-
Share change
-
+1,121,105
-
Total reported value
-
$376,723,063
-
Put/Call ratio
-
0%
-
Price per share
-
$9.85
-
Number of holders
-
110
-
Value change
-
+$11,812,411
-
Number of buys
-
53
-
Number of sells
-
46
Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q3 2018
As of 30 Sep 2018 CYTOKINETICS INC - COMMON STOCK (CYTK) had 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,246,560 shares of stock of the company.
Largest 10 holders included BlackRock Inc., BVF INC/IL, Vanguard Group Inc, LANSDOWNE PARTNERS (UK) LLP, GREAT POINT PARTNERS LLC, STATE STREET CORP, FMR LLC, WASATCH ADVISORS INC, WELLINGTON MANAGEMENT GROUP LLP, and Invesco Ltd..
This table shows 112 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.